eFFECTOR Therapeutics, Inc. logo

eFFECTOR Therapeutics, Inc.

NASDAQ:EFTR

Overview | Financials
Company Name eFFECTOR Therapeutics, Inc.
Symbol EFTR
Currency USD
Price 0.055
Market Cap 258,743
Dividend Yield 0%
52-week-range 0.032 - 20.5
Industry Biotechnology
Sector Healthcare
CEO Dr. Stephen T. Worland Ph.D.
Website https://effector.com

An error occurred while fetching data.

About eFFECTOR Therapeutics, Inc.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung

Related Stocks

LENSAR, Inc. logo

LENSAR, Inc.

LNSR

4.92 USD

Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd.

ENLV

1.355 USD

Synlogic, Inc. logo

Synlogic, Inc.

SYBX

1.55 USD

Longboard Pharmaceuticals, Inc. logo

Longboard Pharmaceuticals, Inc.

LBPH

35.95 USD

Homology Medicines, Inc. logo

Homology Medicines, Inc.

FIXX

0.935 USD

Financials

Numbers are in millions USD

Numbers are in millions USD